Johann Stanek

Pgp-Mediated Interaction Between (R)-[11C]Verapamil and Tariquidar at the Human Blood–Brain Barrier: A Comparison With Rat Data

Martin Bauer, Markus Zeitlinger, Rudolf Karch et al. · Clinical Pharmacology & Therapeutics · 2011 · 118 citations · Full text

Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using (R)-[11C]verapamil PET

Claudia Kuntner, Jens P. Bankstahl, Marion Bankstahl et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2009 · 117 citations · Full text

Pharmacological Study, P-glycoprotein Inhibition, Medicine +9

Tariquidar-Induced P-Glycoprotein Inhibition at the Rat Blood–Brain Barrier Studied with (<i>R</i>)-¹¹C-Verapamil and PET

Jens P. Bankstahl, Claudia Kuntner, Aiman Abrahim et al. · Journal of Nuclear Medicine · 2008 · 103 citations · Full text

Tariquidar and Elacridar Are Dose-Dependently Transported by P-Glycoprotein and Bcrp at the Blood-Brain Barrier: A Small-Animal Positron Emission Tomography and In Vitro Study

Jens P. Bankstahl, Marion Bankstahl, Kerstin Römermann et al. · Drug Metabolism and Disposition · 2013 · 97 citations

Limitations of Small Animal PET Imaging with [18F]FDDNP and FDG for Quantitative Studies in a Transgenic Mouse Model of Alzheimer’s Disease

Claudia Kuntner, Adam Kesner, Martin Bauer et al. · Molecular Imaging and Biology · 2009 · 93 citations

Positron Emission Tomography, Neurodegenerative Diseases, Quantitative Studies +12